SCHEMBL22922526

SCHEMBL22922526

C#CCN(c1ccc(NS(=O)(=O)c2ccccc2C)c2ccccc12)[C@@H](C)CC(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.39
▸ MEN1 O00255 4/20 0.39
▸ G6PD P11413 2/20 0.39
▸ GAA P10253 1/20 0.39
▸ MAP1LC3B Q9GZQ8 1/20 0.39
▸ KEAP1 Q14145 7/20 0.38
▸ NFE2L2 Q16236 4/20 0.38
▸ BRD4 O60885 1/20 0.38
▸ FPR1 P21462 1/20 0.37
▸ MCL1 Q07820 3/20 0.37
▸ BCL2 P10415 1/20 0.37
▸ HKDC1 Q2TB90 3/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ BLM P54132 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ KDM4C Q9H3R0 2/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29540066 1.00 KMT2A (0.39) KMT2AMEN1G6PDGAAMAP1LC3B
SCHEMBL22922681 0.91 KMT2A (0.52) KMT2AMEN1G6PDGAAMAP1LC3B
SCHEMBL29540419 0.91 KMT2A (0.52) KMT2AMEN1G6PDGAAMAP1LC3B
SCHEMBL24299972 0.91 KEAP1 (0.39) KMT2AMEN1G6PDGAAMAP1LC3B
SCHEMBL22922455 0.88 KMT2A (0.47) KMT2AMEN1GAAKEAP1NFE2L2
SCHEMBL29539804 0.88 KMT2A (0.47) KMT2AMEN1GAAKEAP1NFE2L2
SCHEMBL26356949 0.88 KEAP1 (0.42) KMT2AMEN1GAAKEAP1NFE2L2
SCHEMBL28407007 0.87 KEAP1 (0.45) KMT2AMEN1G6PDGAAKEAP1
SCHEMBL25057908 0.87 KEAP1 (0.45) KMT2AMEN1G6PDGAAKEAP1
SCHEMBL26357056 0.87 KEAP1 (0.48) KMT2AMEN1MAP1LC3BKEAP1NFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11773057-B2 Naphthalenesulfonamide compound, preparation method, and application CHINA PHARMACEUTICAL UNIVERSITY (CN) 2023-10-03 — — US disclosed
US-11773057-B2 Naphthalenesulfonamide compound, preparation method, and application CHINA PHARMACEUTICAL UNIVERSITY (CN) 2023-10-03 — — US disclosed
EP-3978471-B1 NAPHTHALENESULFONAMIDE COMPOUND, PREPARATION METHOD, AND APPLICATION UNIV CHINA PHARMA (CN) 2023-02-22 — — EP disclosed
EP-3978471-A1 NAPHTHALENESULFONAMIDE COMPOUND, PREPARATION METHOD, AND APPLICATION China Pharmaceutical University (CN) 2022-04-06 — — EP disclosed
WO-2021012721-A1 NAPHTHALENESULFONAMIDE COMPOUND, PREPARATION METHOD, AND APPLICATION 中国药科大学 2021-01-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11773057-B2 Naphthalenesulfonamide compound, preparation method, and application NFE2L2, KEAP1, NFE2 KMT2A 2133/4885MEN1 4546/4885G6PD 2840/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback